Biomarkers of Metabolic Syndrome in Clinical Trials
This will discuss the latest developments in biomarkers for metabolic syndrome. The topics will include: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) dysfunctional HDL biomarkers in metabolic syndrome, and 3) kidney injury markers and their usefulness in diabetic nephropathy.
Building the Volatile Organic Compound Metabolome
Paul Thomas, Professor of Analytical Science, Loughborough University, speaking at Advances in Metabolic Profiling 2010.
Johan Westerhuis, Assistant Professor University of Amsterdam, speaking at Advances in Metabolic Profiling 2010.
Novel Approaches to Metabolite Profiling and Characterization Based on Ion-Mobility Mass Spectrometry.
John P. Shockcor, Director of Metabolic Profiling, Waters, speaking at Advances in Metabolic Profiling 2010.
The Metabolomic Fingerprints of Genetic and Environmental Factors in the Geneticist’s Old Friend D. melanogaster.
Anders Malmendal, Associate Professor, University of Copenhagen, speaking at Advances in Metabolic Profiling 2010.
Dried Blood Spot Samples for ADME, Biomarker Analysis and Metabolomics
Elwin Verheij, Innovation Manager, TNO, speaking at ADMET Europe
Identification of Biomarkers in Plant Extracts using Liquid Chromatography Mass Spectrometry Analysis
David Portwood of Syngenta, speaking at Advances in Metabolic Profilling.
Conquering Biological Variability by Crossover Designs and Multilevel Data Analysis in Nutritional Metabolomics Studies
Johan Westerhuis, Assistant Professor, Swammerdam Institute for Life Sciences, speaking at Advances in Metabolic Profiling 2009
The Robust Metabolic Network Adaptations in Ultifactorial Diseases as New Targets for Novel Designed Therapies
Marta Cascante, Professor, University of Barcelona, speaking at Advances in Metabolic Profiling 2009